⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Rising Pharma Holdings, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Rising Pharma Holdings, Inc.
↗East Brunswick, New Jersey, USA
Rising Pharma Holdings, Inc. (d/b/a Rising Pharmaceuticals) is a U.S.-based pharmaceutical company that markets and distributes a diverse portfolio of generic prescription drugs, over-the-counter (OTC) solutions, and specialty products. The company focuses on therapeutic areas including cardiovascular, gastrointestinal, urological, pain management, and ophthalmic conditions.
Founded in 1990, the company operates as a private, PE-backed entity. It maintains a vertically integrated business model with manufacturing facilities in the United States and India, and it is known for its robust pipeline of Abbreviated New Drug Applications (ANDAs) filed with the FDA.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generics and Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:201-500
Revenue:$25M-$100M
Founded:1990
Ownership:private
Status:operating
FUNDING
Total Raised:$437M
Investors:H.I.G. Capital
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Trial Phases:-
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Casper Pharma LLC
COMPETITION
Position:Challenger
Competitors:Leading Pharma, Lannett, Par Pharmaceutical, DOC Pharma
LEADERSHIP
Key Executives:
Vimal Kavuru - President & CEO
James Mastakas - Chief Financial Officer
Steven Greenstein - Executive Vice President of Sales and Marketing
Sandeep Mhetre - Chief Scientific Officer
LINKS
Website:risingpharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Rising Pharma Holdings, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.